Jia Jie Bio Business Summary

Jia Jie Biomedical Co., Ltd. (4109.TWO) operates a vertically integrated biotechnology model focused on the research, manufacturing, and distribution of softshell turtle-based nutritional supplements and functional foods. The company generates the vast majority of its revenue—exceeding 94%—from its health supplement segment, headlined by its flagship "Turtle Essence" capsules, which have sold over one billion units. Revenue streams are primarily driven by domestic product sales and processing fees for turtle-derived raw materials, including powder, oil, and eggs. Within the competitive landscape of Taiwan’s health and wellness market, Jia Jie Bio maintains a dominant niche position as the leading specialist in turtle-based nutrition, competing against broader biopharmaceutical and supplement giants such as Grape King Bio (1707.TW), Maywufa Co., Ltd. (1731.TW), and Dr. Wu Skincare (6523.TWO). Under the strategic umbrella of the Taiwan Steel Group (TSG), the company is currently led by Chairman Weng Chung-Chun, a prominent figure with a background in public policy and legislative affairs, and CEO Hsieh Wen-Fang, who oversees the firm’s integration into TSG’s broader "Gratitude, Health, and Hope" ecosystem. General Manager Tseng Ming-Chuan manages day-to-day operations and the company's extensive distribution network, while CFO Lin Qing-Hong serves as the primary spokesperson. The leadership team is backed by the significant institutional resources of Taiwan Steel Group, led by TSG Chairman Hsieh Yu-min, whose acquisition of the company in recent years has pivoted Jia Jie Bio toward modernized R&D and expanded retail footprints across the Asia-Pacific region.